| Page 1217 | Kisaco Research
 

Geneviève Michaux

Partner | FDA and Life Sciences
King & Spalding (BEL)

Geneviève Michaux

Partner | FDA and Life Sciences
King & Spalding (BEL)

Geneviève Michaux

Partner | FDA and Life Sciences
King & Spalding (BEL)
 

Nadia Spiccia

Associate
KIRKLAND & ELLIS INTERNATIONAL LLP

Nadia Spiccia is an associate in Kirkland’s Intellectual Property Litigation Practice Group in London. Nadia’s practice focuses on complex cross border and multijurisdictional life sciences patent disputes requiring significant coordination across multiple forums at both first instance and on appeal. With over 12 years’ experience supporting global pharma/biopharma and a background in chemistry, Nadia leverages her legal and technical experience to provide strategic counselling.

Nadia Spiccia

Associate
KIRKLAND & ELLIS INTERNATIONAL LLP

Nadia Spiccia

Associate
KIRKLAND & ELLIS INTERNATIONAL LLP

Nadia Spiccia is an associate in Kirkland’s Intellectual Property Litigation Practice Group in London. Nadia’s practice focuses on complex cross border and multijurisdictional life sciences patent disputes requiring significant coordination across multiple forums at both first instance and on appeal. With over 12 years’ experience supporting global pharma/biopharma and a background in chemistry, Nadia leverages her legal and technical experience to provide strategic counselling. Prior to joining Kirkland, Nadia was Head of Patent Litigation - ex NA at Sandoz responsible for the launch and litigation of Sandoz’s small molecule and biosimilars worldwide apart from North America. Prior to this Nadia was Head of Legal and Company Secretary - ANZ for Mylan (now Viatris). Nadia was recognised by Managing IP as a Notable Practitioner in the 2021 edition of its IP Stars guide and as a Corporate IP Star – Europe in the 2019-2020 editions. She was also named to the list of Leading In-House Intellectual Property & TMT Lawyers – Australia by Doyle’s Guide in the 2019-2020 editions.

One of the biggest challenges in the US is managing the cost of healthcare.  Although we have high healthcare costs in the US, our life expectancy is still average.  In this talk we will look at some of the core causes of healthcare costs and what modern AI hardware can do to lower these costs.  We will see that faster and bigger GPUs alone will not save us.  We need detailed models to across a wide swath of our communities and perform early interventions.  We need accurate models of our world and the ability to simulate the impact of policy changes to overall healthcare costs.  We need new MIMD hardware with cores and memory architecture that keep cores fed with the right data.

Enterprise AI
ML at Scale
Systems Design
Data Science
Software Engineering
Systems Engineering

Author:

Dan McCreary

Distinguished Engineer, Graph & AI
Optum

Dan is a distinguished engineer in AI working on innovative database architectures including document and graph databases. He has a strong background in semantics, ontologies, NLP and search. He is a hands-on architect and like to build his own pilot applications using new technologies. Dan started the NoSQL Now! Conference (now called the Database Now! Conferences). He also co-authored the book Making Sense of NoSQL, one of the highest rated books on Amazon on the topic of NoSQL. Dan worked at Bell Labs as a VLSI circuit designer where he worked with Brian Kernighan (of K&R C). Dan also worked with Steve Jobs at NeXT Computer.

Dan McCreary

Distinguished Engineer, Graph & AI
Optum

Dan is a distinguished engineer in AI working on innovative database architectures including document and graph databases. He has a strong background in semantics, ontologies, NLP and search. He is a hands-on architect and like to build his own pilot applications using new technologies. Dan started the NoSQL Now! Conference (now called the Database Now! Conferences). He also co-authored the book Making Sense of NoSQL, one of the highest rated books on Amazon on the topic of NoSQL. Dan worked at Bell Labs as a VLSI circuit designer where he worked with Brian Kernighan (of K&R C). Dan also worked with Steve Jobs at NeXT Computer.

 

Chad Shear

Partner
Cooley

Chad is a principal in the firm’s San Diego office and is the go-to patent litigator for numerous multinational life sciences companies — including Gilead, GSK, iCeutica, Iroko, Coherus Biosciences and Dainippon Sumitomo Pharma — whose marquee products deliver billions of dollars in annual revenues. He draws on his litigation experience, extensive network of scientific and business experts, and detailed knowledge of his clients’ companies to provide strategic legal counsel on a wide range of business matters.

Chad Shear

Partner
Cooley

Chad Shear

Partner
Cooley

Chad is a principal in the firm’s San Diego office and is the go-to patent litigator for numerous multinational life sciences companies — including Gilead, GSK, iCeutica, Iroko, Coherus Biosciences and Dainippon Sumitomo Pharma — whose marquee products deliver billions of dollars in annual revenues. He draws on his litigation experience, extensive network of scientific and business experts, and detailed knowledge of his clients’ companies to provide strategic legal counsel on a wide range of business matters. With extensive global experience, including serving as lead attorney in complex patent proceedings, trials and appeals across Asia, Europe, North America, and Australia, Chad has proven to be a results-focused, hands-on leader known for assembling and managing effective, collaborative teams across multiple time zones, firms, and languages.

Chip Design
Edge AI
Enterprise AI
Novel AI Hardware
Systems Design
Hardware Engineering
Software Engineering
Systems Engineering

Author:

Harshit Khaitan

Director, AI Accelerators
Meta

Harshit Khaitan is the Director of AI Accelerator at Meta where he leads building AI Accelerators for Reality labs products. Prior to Meta, he was technical lead and co-founder for the Edge Machine learning accelerators at Google, responsible for MLA in Google Pixel 4 (Neural Core) and Pixel 6 (Google Tensor SoC). He has also held individual and technical leadership positions at Google’s first Cloud TPU, Nvidia Tegra SoCs and Nvidia GPUs. He has 10+ US and international patents in On-device AI acceleration. He has a Master’s degree in Computer Engineering from North Carolina State University and a Bachelor’s degree in Electrical Engineering from Manipal Institute of Technology, India.

Harshit Khaitan

Director, AI Accelerators
Meta

Harshit Khaitan is the Director of AI Accelerator at Meta where he leads building AI Accelerators for Reality labs products. Prior to Meta, he was technical lead and co-founder for the Edge Machine learning accelerators at Google, responsible for MLA in Google Pixel 4 (Neural Core) and Pixel 6 (Google Tensor SoC). He has also held individual and technical leadership positions at Google’s first Cloud TPU, Nvidia Tegra SoCs and Nvidia GPUs. He has 10+ US and international patents in On-device AI acceleration. He has a Master’s degree in Computer Engineering from North Carolina State University and a Bachelor’s degree in Electrical Engineering from Manipal Institute of Technology, India.

 

Sharada Devarasetty

Head of Biopharmaceuticals Patents
Sandoz

Sharada has spent the last decade building global IP strategies to launch biosimilars.  She started her career in the US with the patent litigation group at Proskauer Rose, participating in several ITC litigations in addition to her district court docket.  In 2012, she moved to Boehringer Ingelheim to begin her career in the then-new and exciting biosimilars market.  There she helped build strategies for most of the first wave biosimilar, in addition to advising her client how to prepare for global biosimilar litigation.  More recently, she leads the biosimilar IP team at Sandoz, a global l

Sharada Devarasetty

Head of Biopharmaceuticals Patents
Sandoz

Sharada Devarasetty

Head of Biopharmaceuticals Patents
Sandoz

Sharada has spent the last decade building global IP strategies to launch biosimilars.  She started her career in the US with the patent litigation group at Proskauer Rose, participating in several ITC litigations in addition to her district court docket.  In 2012, she moved to Boehringer Ingelheim to begin her career in the then-new and exciting biosimilars market.  There she helped build strategies for most of the first wave biosimilar, in addition to advising her client how to prepare for global biosimilar litigation.  More recently, she leads the biosimilar IP team at Sandoz, a global leader in biosimilars, for the next wave of launches.

 

Emmanuele Degortes

Global Head of Patient, Innovation and Access Policy
Vifor Pharma

Emanuele is the Global Head of Patient, Innovation and Access Policy at Vifor Pharma, a global pharmaceutical company headquartered in Switzerland, specialized in iron deficiency, nephrology and rare conditions. In his role, Emanuele coordinates the company’s government affairs and patient advocacy engagement at EU, international and country level. Previously Emanuele led Biogen’s European Public Policy and Government Affairs activities and was a Director in the Healthcare Practice of FTI Consulting.

Emmanuele Degortes

Global Head of Patient, Innovation and Access Policy
Vifor Pharma

Emmanuele Degortes

Global Head of Patient, Innovation and Access Policy
Vifor Pharma

Emanuele is the Global Head of Patient, Innovation and Access Policy at Vifor Pharma, a global pharmaceutical company headquartered in Switzerland, specialized in iron deficiency, nephrology and rare conditions. In his role, Emanuele coordinates the company’s government affairs and patient advocacy engagement at EU, international and country level. Previously Emanuele led Biogen’s European Public Policy and Government Affairs activities and was a Director in the Healthcare Practice of FTI Consulting. In his spare time he runs a film festival on a deserted island off the coast of Sardinia. 

 

Xisca Borrás

Partner
Bristow (UK)

Xisca Borrás

Partner
Bristow (UK)

Xisca Borrás

Partner
Bristow (UK)
 

Hilary Jones

Senior Director Legal Pharmaceutical Regulation
BioNTech

Hilary Jones

Senior Director Legal Pharmaceutical Regulation
BioNTech

Hilary Jones

Senior Director Legal Pharmaceutical Regulation
BioNTech